Expression of hypoxia‐inducible factor‐1α in esophageal squamous cell carcinoma

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Cancer Science

• Publication date

  2005-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1349-7006.2005.00025.xPMID 15771621PMCID PMC11158823
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression of hypoxia-inducible factor (HIF)-1α is associated with vascular endothelial growth factor expression and tumour angiogenesis in human oesophageal squamous cell carcinoma

  2004cited by this paper
• Expression of hypoxia-inducible factor (HIF)-1alpha is associated with vascular endothelial growth factor expression and tumour angiogenesis in human oesophageal squamous cell carcinoma.

  2004cited by this paper
• Levels of hypoxia‐inducible factor‐1α independently predict prognosis in patients with lymph node negative breast carcinoma

  2003cited by this paper
• Overexpression of hypoxia-inducible-factor 1α(HIF-1α) in oesophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage

  2003cited by this paper
• Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1.

  2003cited by this paper
• Expression of hypoxia‐inducible factor‐1α is associated with tumor vascularization in human colorectal carcinoma

  2003cited by this paper
• Expression of hypoxia-inducible factors in human renal cancer: relationship to angiogenesis and to the von Hippel-Lindau gene mutation.

  2002cited by this paper
• Relation of Hypoxia-inducible Factor-2α (HIF-2α) Expression in Tumor-infiltrative Macrophages to Tumor Angiogenesis and the Oxidative Thymidine Phosphorylase Pathway in Human Breast Cancer

  2002cited by this paper
• Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.

  2002cited by this paper
• Relation of hypoxia-inducible factor-2 alpha (HIF-2 alpha) expression in tumor-infiltrative macrophages to tumor angiogenesis and the oxidative thymidine phosphorylase pathway in Human breast cancer.

  2002cited by this paper
• Clinical significance of serum vascular endothelial growth factor in esophageal squamous cell carcinoma

  2001cited by this paper
• Expression of hypoxia-inducible factor 1alpha in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy.

  2001cited by this paper
• HIF‐1 is expressed in normoxic tissue and displays an organ‐specific regulation under systemic hypoxia

  2001cited by this paper
• Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival

  2001cited by this paper
• Hypoxia inducible factor (HIF-1a and HIF-2a) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy.

  2001cited by this paper
• Relation of vascular endothelial growth factor production to expression and regulation of hypoxia-inducible factor-1 alpha and hypoxia-inducible factor-2 alpha in human bladder tumors and cell lines.

  2001cited by this paper
• Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer.

  2001cited by this paper
• Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha.

  2000cited by this paper
• Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer.

  2000cited by this paper
• The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages.

  2000cited by this paper
• The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages

  2000cited by this paper
• The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

  1999cited by this paper
• Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases.

  1999cited by this paper
• Influence of the hypoxic subvolume on the survival of patients with head and neck cancer.

  1999cited by this paper
• Regulation of hypoxia-inducible factor 1α is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway

  1998cited by this paper
• Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis

  1998cited by this paper
• Stabilization of wild-type p53 by hypoxia-inducible factor 1α

  1998cited by this paper
• In oesophageal squamous cell carcinoma vascular endothelial growth factor is associated with p53 mutation, advanced stage and poor prognosis.

  1998cited by this paper
• HIF‐1α is required for solid tumor formation and embryonic vascularization

  1998cited by this paper
• Increased expression of hypoxia inducible factor-1alpha in rat and human prostate cancer.

  1998cited by this paper
• HIF-1 alpha is required for solid tumor formation and embryonic vascularization.

  1998cited by this paper
• Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway.

  1998cited by this paper
• Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth.

  1997cited by this paper
• The biology of vascular endothelial growth factor.

  1997cited by this paper
• Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma

  1997cited by this paper
• Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix.

  1996cited by this paper
• Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1

  1996cited by this paper
• The Mouse Gene for Vascular Endothelial Growth Factor

  1996cited by this paper
• Slowed Release of Thrombin-cleaved Factor VIII from von Willebrand Factor by a Monoclonal and a Human Antibody Is a Novel Mechanism for Factor VIII Inhibition*

  1996cited by this paper
• Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma.

  1996cited by this paper
• Activation of Hypoxia-inducible Transcription Factor Depends Primarily upon Redox-sensitive Stabilization of Its α Subunit*

  1996cited by this paper
• Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours

  1996cited by this paper
• Purification and Characterization of Hypoxia-inducible Factor 1 (*)

  1995cited by this paper
• Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status

  1994cited by this paper
• General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia.

  1993cited by this paper
• Wild-type p53 can down-modulate the activity of various promoters.

  1991cited by this paper

• Hypoxia induces chemoresistance of esophageal cancer cells to cisplatin through regulating the lncRNA-EMS/miR-758-3p/WTAP axis

  2021cites this paper
• Hypoxia inducible factor-1α cooperates with histone Lys methylation to predict prognosis in esophageal squamous cell carcinoma.

  2021cites this paper
• Esophageal Microenvironment: From Precursor Microenvironment to Premetastatic Niche

  2020cites this paper
• Clinical significance of hypoxia-inducible factor 1α, and its correlation with p53 and vascular endothelial growth factor expression in resectable esophageal squamous cell carcinoma

  2020cites this paper
• Esophageal Microenvironment: From Precursor Microenvironment to Premetastatic Niche

  2020cites this paper
• The Critical Role of Hypoxic Microenvironment and Epigenetic Deregulation in Esophageal Cancer Radioresistance

  2019cites this paper
• Glucose transporter 1 and prognosis in cancer

  2019cites this paper
• Nanoparticle-Embedded Electrospun Fiber-Covered Stent to Assist Intraluminal Photodynamic Treatment of Oesophageal Cancer.

  2019cites this paper
• Low HIF-1α and low EGFR mRNA Expression Significantly Associate with Poor Survival in Soft Tissue Sarcoma Patients; the Proteins React Differently

  2018cites this paper
• Genetic polymorphisms of ATG5 predict survival and recurrence in patients with early-stage esophageal squamous cell carcinoma

  2017cites this paper
• Siah-1 is associated with expression of hypoxia-inducible factor-1α in oral squamous cell carcinoma.

  2017cites this paper
• Hypoxia and hypoxia response-associated molecular markers in esophageal cancer: A systematic review.

  2017cites this paper
• Inducible Nitric Oxide Synthase in the Carcinogenesis of Gastrointestinal Cancers

  2017cites this paper
• Role of Hypoxia-Inducible Factor (HIF) in the Initiation of Cancer and Its Therapeutic Inhibitors

  2017cites this paper
• Expression of hypoxia inducible factor 1 alpha and its clinical significance in esophageal carcinoma: A meta-analysis

  2017cites this paper
• STAT3 regulates hypoxia-induced epithelial mesenchymal transition in oesophageal squamous cell cancer

  2016cites this paper
• Hypoxia and Hypoxia-Inducible Factors in Leukemias

  2016cites this paper
• Visible-absorption spectroscopy as a biomarker to predict treatment response and prognosis of surgically resected esophageal cancer

  2016cites this paper
• Contribution of MicroRNAs to autoimmune diseases

  2016cites this paper
• Under hypoxia conditions contactin-1 regulates the migration of Mkn45 cells through the RhoA pathway

  2015cites this paper
• Metabolic activity on [18f]-fluorodeoxyglucose-positron emission tomography/computed tomography and glucose transporter-1 expression might predict clinical outcomes in patients with limited disease small-cell lung cancer who receive concurrent chemoradiation.

  2014cites this paper
• Clinicopathological and prognostic significance of hypoxia-inducible factor-1α in esophageal squamous cell carcinoma: a meta-analysis

  2014cites this paper
• Chromatin , Gene , and RNA Regulation Prognostic Potential of DNA Methylation and Transcript Levels of HIF 1 A and EPAS 1 in Colorectal Cancer

  2014cites this paper
• Role of hypoxia‐inducible factor‐1α expression in regulatory T cells on nasal polypogenesis

  2014cites this paper
• Prognostic Potential of DNA Methylation and Transcript Levels of HIF1A and EPAS1 in Colorectal Cancer

  2014cites this paper
• Clinical impact of the Warburg effect in gastrointestinal cancer (review).

  2014cites this paper
• GYY4137, a hydrogen sulfide (H₂S) donor, shows potent anti-hepatocellular carcinoma activity through blocking the STAT3 pathway.

  2014cites this paper
• Role of Compartmentalization on HiF-1α Degradation Dynamics during Changing Oxygen Conditions: A Computational Approach

  2014cites this paper
• Role of cancer-related inflammation in esophageal cancer.

  2013cites this paper
• Cytokines Association with Clinical and Pathological Changes in Esophageal Squamous Cell Carcinoma

  2013cites this paper
• A Meta-Analysis of HIF-1α and Esophageal Squamous Cell Carcinoma (ESCC) Risk

  2013cites this paper
• Clinicopathological significance of hypoxia-inducible factor-1 alpha (HIF-1α) expression in gastric cancer

  2013cites this paper
• Hypoxia-regulated gene expression and prognosis in loco-regional gastroesophageal cancer

  2013cites this paper
• Contactin-1 (CNTN-1) overexpression is correlated with advanced clinical stage and lymph node metastasis in oesophageal squamous cell carcinomas.

  2012cites this paper
• HIF-1α siRNA and cisplatin in combination suppress tumor growth in a nude mice model of esophageal squamous cell carcinoma.

  2012influential citation
• Clinicopathological Significance of Hypoxia-Inducible Factor-1 Alpha (HIF-1α) Expression in Gastric Cancer

  2012cites this paper
• Hypoxia induces IGFBP3 in esophageal squamous cancer cells through HIF‐1α‐mediated mRNA transcription and continuous protein synthesis

  2012cites this paper
• The Relationship Between GLUT-1 and Vascular Endothelial Growth Factor Expression and 18F-FDG Uptake in Esophageal Squamous Cell Cancer Patients

  2012cites this paper
• The role of hypoxia inducible factor-1alpha in gynecological cancer.

  2011cites this paper
• Small interfering RNA targeting HIF-1α reduces hypoxia-dependent transcription and radiosensitizes hypoxic HT 1080 human fibrosarcoma cells in vitro

  2011cites this paper
• Prognostic value of hypoxia inducible factor 1α in esophageal squamous cell carcinoma.

  2011cites this paper
• Expressions of hypoxia-inducible factor-1α and hexokinase-II in gastric adenocarcinoma: the impact on prognosis and correlation to clinicopathologic features

  2011cites this paper
• Clinical significance of HIF-1alpha expression in patients with esophageal cancer treated with concurrent chemoradiotherapy.

  2011cites this paper
• HIF-1α and VEGF are associated with disease progression in esophageal carcinoma.

  2011cites this paper
• Correlations of hypoxia-inducible factor-1α/hypoxia-inducible factor-2α expression with angiogenesis factors expression and prognosis in non-small cell lung cancer.

  2011cites this paper
• Progression Free Survival

  2010cites this paper
• Clinicopathological implications of expressions of hypoxia-related molecules in esophageal superficial squamous cell carcinoma.

  2010cites this paper
• The role of hypoxia-inducible factor-1 in hyperthermia-induced tumor reoxygenation and therapy resistance

  2010cites this paper
• Hypoxia activates the cyclooxygenase-2-prostaglandin E synthase axis.

  2010cites this paper
• Validated analysis of HIF-1alpha expression in cancer cells using a controlled and comparative immunoassay.

  2010cites this paper
• The relation between hypoxia‐inducible factor (HIF)‐1alpha expression with p53 expression and outcome in surgically treated supraglottic laryngeal cancer

  2009cites this paper
• Upregulation of Hypoxia-Inducible Factor-1α mRNA and its Clinical Significance in Non-small Cell Lung Cancer

  2009cites this paper
• Therapeutic strategy targeting the mTOR–HIF‐1α–VEGF pathway in ovarian clear cell adenocarcinoma

  2009cites this paper
• The Clinicopathological Significance of Tissue Levels of Hypoxia-Inducible Factor-1α and Vascular Endothelial Growth Factor in Gastric Cancer

  2009influential citation
• Immunohistochemical detection of changes in tumor hypoxia.

  2009cites this paper
• Increase in gene dosage is a mechanism of HIF‐1α constitutive expression in head and neck squamous cell carcinomas

  2009cites this paper
• HIF-1alpha protein expression is associated with the environmental inflammatory reaction in Barrett's metaplasia.

  2009cites this paper
• Role of Hypoxia-inducible factor-1α and Survivin in colorectal carcinoma progression

  2008cites this paper
• ENMD-1198, a novel tubulin-binding agent reduces HIF-1alpha and STAT3 activity in human hepatocellular carcinoma(HCC) cells, and inhibits growth and vascularization in vivo

  2008cites this paper
• The cellular adaptations to hypoxia as novel therapeutic targets in childhood cancer.

  2008cites this paper
• Solid tumor physiology and hypoxia-induced chemo/radio-resistance: novel strategy for cancer therapy: nitric oxide donor as a therapeutic enhancer.

  2008cites this paper
• Expression of hypoxia-inducible factor 1a in the nasal polyps by real-time RT-PCR and immunohistochemistry

  2008cites this paper
• Hypoxia and prognosis: the oxygen tension mounts.

  2007cites this paper
• Hypoxia-inducible factor (HIF) in human tumorigenesis.

  2007cites this paper
• Vascular endothelial growth factor, its receptor Flk-1, and hypoxia inducible factor-1alpha are involved in malignant transformation in dysplastic nodules of the liver.

  2007cites this paper
• Increased expression of hypoxia-inducible factor 1alpha in the nasal polyps.

  2007cites this paper
• Expression of hypoxia-inducible factor-1 alpha is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.

  2007cites this paper
• Hypoxia in cancer: significance and impact on clinical outcome

  2007cites this paper
• Expression and clinical significance of HIF-1α, VEGF and Survivin in esophageal squamous cell carcinoma

  2007cites this paper
• Review Hypoxia-inducible factor (HIF) in human tumorigenesis

  2007cites this paper
• The Potential Role of Intrinsic Hypoxia Markers as Prognostic Variables in Cancer

  2007cites this paper
• HIF-1alpha mRNA is not associated with histopathological regression following neoadjuvant chemoradiation in esophageal cancer.

  2006cites this paper
• Overexpression of hypoxia-inducible factor-1 alpha in gastric adenocarcinoma

  2006cites this paper
• Regulation of angiogenesis by hypoxia-inducible factor 1.

  2006cites this paper
• Up-regulation of hypoxia-inducible factor-1 alpha and VEGF mRNAs in peritoneal dissemination of patients with gastric cancer.

  2006cites this paper